A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
- 1 October 1991
- Vol. 68 (7) , 1495-1500
- https://doi.org/10.1002/1097-0142(19911001)68:7<1495::aid-cncr2820680705>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of Combined Intrapleural Administration of Lactobacillus casei (LC9018) and Adriamycin on Experimental Malignant Pleurisy in MiceJapanese Journal of Cancer Research, 1989
- Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: A randomized studyJournal of Surgical Oncology, 1987
- Inhibition of tumor metastasis of lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus caseiCancer Immunology, Immunotherapy, 1987
- Clinical Experience With Tetracycline Pleurodesis of Malignant Pleural EffusionsSouthern Medical Journal, 1987
- Augmentation of Mouse Natural Killer Cell Activity by Lactobacillus casei and Its Surface AntigensMicrobiology and Immunology, 1984
- Macrophage Activation by Lactobacillus casei in MiceMicrobiology and Immunology, 1983
- Intrapleural tetracycline in malignant pleural effusions: A randomized studyCancer, 1983
- The treatment of malignant pleural effusionsCancer, 1974